Catalase activity deficiency sensitizes multidrug-resistant Mycobacterium tuberculosis to the ATP synthase inhibitor bedaquiline
Abstract Multidrug-resistant tuberculosis (MDR-TB), defined as resistance to the first-line drugs isoniazid and rifampin, is a growing source of global mortality and threatens global control of tuberculosis disease. The diarylquinoline bedaquiline has recently emerged as a highly efficacious drug ag...
        Saved in:
      
    
          | Main Authors: | , , , , , , , , , , , , , | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | Nature Portfolio
    
        2024-11-01 | 
| Series: | Nature Communications | 
| Online Access: | https://doi.org/10.1038/s41467-024-53933-8 | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
 
       